Invited to Attend China-Spain Biomedical...
As a healthcare company proactively participating in the COVID-19 combat, Biohit (Hefei) was invited to be present at the China-Spain Biomed...
CE Mark Certification Received for SARS-...
We're very pleased to announce that we have been awarded the CE marking for our SARS-CoV-2 Antigen Rapid Test (Colloidal Gold Method). ...
Corporate relocation! Meet our brand-new...
Biohit (Hefei) moved to new site in the early February. This relocation is part of our strategic initiative that focuses on ope...
Biohit (Hefei) SARS-CoV-2 antigen rapid ...
On September 29th, 2020, the SARS-CoV-2 antigen rapid test kit (fluorescence immunochromatography) independently developed and manufactur...
The first innovative blood antigen test ...
The SARS-CoV-2 antigen quantitative assay kit (enzyme-linked immunoassay) independently developed and produced by Biohit Healthcare (Hefe...
Biohit SARS-CoV-2 IgM/IgG Antibody Test ...
On March 18th, the SARS-CoV-2 IgM/IgG Antibody Test Kit(Colloidal Gold Method) produced by Biohit Healthcare(Hefei) Co., Ltd. passed the ...
Biohit SARS-CoV-2 Antibody Test Kit Obta...
On June 18th 2020, Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit (Colloidal Gold Method) obtained U.S. Food and Drug Administratio...
Biohit SARS-CoV-2 Antigen Quantitative A...
On June 12th, the SARS-CoV-2 Antigen quantitative assay kit (enzyme-linked immunoassay) produced by Biohit Healthcare(Hefei) Co., Ltd. pa...